CLASS I ONGOING Device recall · Reported 18 Jun 2025 · FDA Enforcement Report

Ivenix Infusion System Lvp Blood Products Administration recalled

Fresenius Kabi USA is recalling Ivenix Infusion System Lvp Blood Products Administration Set, Dual-Inlet, Low-Sorbing, distributed in 18 states. The recall was initiated on 12 May 2025 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesModel No. SET-0014-20; UDI 20811505030034; Lot No. FA24K05015.
Quantity recalled14,280 units (724 cases)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1869-2025
FDA event ID
96880
Recalling firm
Fresenius Kabi USA, North Andover, MA
Classification
Class I
Status
Ongoing
Recall initiated
12 May 2025
FDA classified
6 Jun 2025
Reported
18 Jun 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Particulate Matter

Timeline

12 May 2025Recall initiated by company
6 Jun 2025Classified by FDA+25 days
18 Jun 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Mis-assembly error of Blood Products Administrations Sets where the 200-micron drip chamber filter may be incorrectly positioned and unable to filter out large blood particulates.

Product as listed by the FDA

IVENIX INFUSION SYSTEM LVP Blood Products Administration Set, Dual-Inlet, Low-Sorbing, Y-Site, Mesh Filter, 15 mL. Intravascular Administration Set.

Where it was distributed

US distribution: CA, CO, DE, GA, IL, MD, MI, MN, MS, NC, NJ, NV, OK, SC, TX, VA, WA & WI.

CaliforniaColoradoDelawareGeorgiaIllinoisMarylandMichiganMinnesotaMississippiNorth CarolinaNew JerseyNevadaOklahomaSouth CarolinaTexasVirginiaWashingtonWisconsin

Questions about this recall

Why was it recalled?

Mis-assembly error of Blood Products Administrations Sets where the 200-micron drip chamber filter may be incorrectly positioned and unable to filter out large blood particulates.

Which lots are affected?

Model No. SET-0014-20; UDI 20811505030034; Lot No. FA24K05015.

Where was it sold?

US distribution: CA, CO, DE, GA, IL, MD, MI, MN, MS, NC, NJ, NV, OK, SC, TX, VA, WA & WI.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fresenius Kabi USA

All 95

Other Heart & Vascular Devices recalls

All 6,199